Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
FDA Expands Approval For Bristol Myers Squibb's Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies
Via Benzinga
Exposures Product Safety
Tickers BMY
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Via Benzinga
Exposures Product Safety
Tickers MRNA
Tesla Recalls 2024: More Than 125,000 Vehicles Recalled for Seatbelt Issues
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers NVOS TSLA
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Via Investor's Business Daily
Exposures Product Safety
Tickers GSK MRNA PFE
First in the world Sungen Biomedical obtains FDA’s clinical trial approval of IND SGC001 as an emergency use antibody drug for AMI
Via Get News
Topics Death
Exposures Death Product Safety
REMSleep Holdings Shareholder Update
Via TheNewswire.com
Exposures Product Safety
Tickers RMSL
Woman-Owned Small Family Business, Academic Entertainment, Transitions Leadership to the Second Generation
Via Get News
Topics Product Recall
Exposures Legal Product Safety
US Eco-Friendly Direct Thermal Labels for Prepared Food Packaging Announced
Via Press Release Distribution Service
Exposures Product Safety
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Via Benzinga
Exposures Product Safety
Tickers REGN SNY
BREAKING: Tesla Recalls Over 125,000 Cars To Fix Faulty Seat Belt Warnings
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
Via Benzinga
Exposures Product Safety
Tickers LLY
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Via Benzinga
Exposures Product Safety
Tickers AMGN AZN
REMSleep Holdings Shareholder Update
Via NewMediaWire
Exposures Product Safety
Tickers RMSL
Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
Via News Direct
Exposures Product Safety
Tickers IOVA OTLC
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Exposures Product Safety
Tickers LLY MRNA PFE PRME
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
Via Benzinga
Exposures Product Safety
Tickers PFE RY SRPT TSX:RY
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8® in ALS
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers AGIO RPRX
The Sandbox’s Journey from Mobile Gaming to a Leading Web3 Platform with Sebastien Borget
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Compumedics set for record-breaking $46 million FY24 revenue
Via News Direct
Exposures Product Safety
Tickers ASX:CMP
BLUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
Compumedics set for record-breaking $46 million FY24 revenue
Via TheNewswire.com
Exposures Product Safety
Tickers ASX:CMP
BLUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
Ken’s Hardwood Barbecue Hosts Watch Party for Pat Sajak’s Farewell on Wheel of Fortune
Via Get News
Topics Product Recall
Exposures COVID-19 Legal Product Safety
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
Via Benzinga
Exposures Product Safety
Tickers GH
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
Via Investor's Business Daily
Exposures Product Safety
Tickers EXAS GH
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Via Benzinga
Exposures Product Safety
Tickers AMGN BMY VSTM
BLUE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
BLUE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important May 28 Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
CCHR Commends Lawsuit Filed over FDA’s Failure to Act on Citizen Petition to Update Antidepressant Labeling for Persistent Sexual Problems
Via Press Release Distribution Service
Topics Lawsuit
Exposures Financial Legal Product Safety
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.